STAT1 and melanoma: Melanoma cells exposed to recombinant IFN protein [either type I (alpha, beta) or type II (gamma)] quickly activated the interferon signaling pathway, as evidenced by heavy phosphorylation of STAT1 as early as 30 min following IFN treatment (Fig. 3a, b).